These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 17683282

  • 1. Aldosterone and end-organ damage.
    Marney AM, Brown NJ.
    Clin Sci (Lond); 2007 Sep; 113(6):267-78. PubMed ID: 17683282
    [Abstract] [Full Text] [Related]

  • 2. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M, Fujita T.
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [Abstract] [Full Text] [Related]

  • 3. [Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management].
    Horký K.
    Vnitr Lek; 2011 Dec; 57(12):1012-6. PubMed ID: 22277034
    [Abstract] [Full Text] [Related]

  • 4. Vascular actions of aldosterone.
    Briet M, Schiffrin EL.
    J Vasc Res; 2013 Dec; 50(2):89-99. PubMed ID: 23172373
    [Abstract] [Full Text] [Related]

  • 5. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
    Laragh JH.
    J Hum Hypertens; 1995 Jun; 9(6):385-90. PubMed ID: 7473515
    [Abstract] [Full Text] [Related]

  • 6. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 7. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W, Fujita T.
    Clin Exp Pharmacol Physiol; 2013 Dec 28; 40(12):929-36. PubMed ID: 24111570
    [Abstract] [Full Text] [Related]

  • 8. Rapid actions of aldosterone in vascular health and disease--friend or foe?
    Skøtt O, Uhrenholt TR, Schjerning J, Hansen PB, Rasmussen LE, Jensen BL.
    Pharmacol Ther; 2006 Aug 28; 111(2):495-507. PubMed ID: 16413609
    [Abstract] [Full Text] [Related]

  • 9. Mineralocorticoid receptor activation in myocardial infarction and failure: recent advances.
    Galuppo P, Bauersachs J.
    Eur J Clin Invest; 2012 Oct 28; 42(10):1112-20. PubMed ID: 22536780
    [Abstract] [Full Text] [Related]

  • 10. Review of aldosterone- and angiotensin II-induced target organ damage and prevention.
    Struthers AD, MacDonald TM.
    Cardiovasc Res; 2004 Mar 01; 61(4):663-70. PubMed ID: 14985063
    [Abstract] [Full Text] [Related]

  • 11. Non-classical actions of the mineralocorticoid receptor: misuse of EGF receptors?
    Grossmann C, Gekle M.
    Mol Cell Endocrinol; 2007 Oct 15; 277(1-2):6-12. PubMed ID: 17692454
    [Abstract] [Full Text] [Related]

  • 12. RALES, EPHESUS and redox.
    Funder JW.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):121-5. PubMed ID: 15860254
    [Abstract] [Full Text] [Related]

  • 13. Aldosterone, mineralocorticoid receptor, and heart failure.
    Messaoudi S, Azibani F, Delcayre C, Jaisser F.
    Mol Cell Endocrinol; 2012 Mar 24; 350(2):266-72. PubMed ID: 21784127
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Why are mineralocorticoid receptor antagonists cardioprotective?
    Chai W, Danser AH.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec 24; 374(3):153-62. PubMed ID: 17075718
    [Abstract] [Full Text] [Related]

  • 18. Aldosterone and end-organ damage.
    Brown NJ.
    Curr Opin Nephrol Hypertens; 2005 May 24; 14(3):235-41. PubMed ID: 15821416
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
    Chrissobolis S.
    Curr Hypertens Rev; 2017 May 24; 13(1):46-56. PubMed ID: 28245785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.